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Abstract
Diet composition may affect blood pressure (BP), but the mechanisms are unclear. The aim of the present study was to compare postpran-
dial BP-related responses to the ingestion of pea protein, milk protein and egg-white protein. In addition, postprandial BP-related responses
to the ingestion of maltodextrin were compared with those to the ingestion of sucrose and a protein mix. We hypothesised that lower post-
prandial total peripheral resistance (TPR) and BP levels would be accompanied by higher plasma concentrations of nitric oxide, insulin,
glucagon-like peptide 1 (GLP-1) and glucagon. On separate occasions, six meals were tested in a randomised order in forty-eight overweight
or obese adults with untreated elevated BP. Postprandial responses of TPR, BP and plasma concentrations of insulin, glucagon, GLP-1 and
nitrite, nitroso compounds (RXNO) and S-nitrosothiols (NOx) were measured for 4 h. No differences were observed in TPR responses. Post-
prandial BP levels were higher after the ingestion of the egg-white-protein meal than after that of meals containing the other two proteins
(P#0·01). The ingestion of the pea-protein meal induced the highest NOx response (P#0·006). Insulin and glucagon concentrations were
lowest after the ingestion of the egg-white-protein meal (P#0·009). Postprandial BP levels were lower after the ingestion of the maltodextrin
meal than after that of the protein mix and sucrose meals (P#0·004), while postprandial insulin concentrations were higher after the inges-
tion of the maltodextrin meal than after that of the sucrose and protein mix meals after 1–2 h (P#0·0001). Postprandial NOx, GLP-1 and
glucagon concentrations were lower after the ingestion of the maltodextrin meal than after that of the protein mix meal (P#0·008). In con-
clusion, different protein and carbohydrate sources induce different postprandial BP-related responses, which may be important for BP
management. Lower postprandial BP levels are not necessarily accompanied by higher NOx, insulin, glucagon or GLP-1 responses.
Key words: Protein sources: Carbohydrates: Blood pressure
The effect of dietary proteins on blood pressure (BP) has been
evaluated in two recent meta-analyses, which concluded that
replacement of part of dietary carbohydrates with proteins is
beneficial in BP management(1,2). It is still unclear whether
different dietary proteins have different effects on BP(3). Ran-
domised trials comparing the effects of prolonged intake of
different types of proteins or different amino acids on BP
are scarce. Mainly, soya and milk proteins have been studied
in this context, and a recent meta-analysis has shown that soya
and milk proteins decrease BP to a similar extent(4). The post-
prandial BP responses to the ingestion of the milk proteins
casein and whey have been found to be similar to those to
the ingestion of a carbohydrate control(5). In a randomised
clinical trial on the effects of PROteins on blood PRESsure
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Abbreviations: ACE, angiotensin-converting enzyme; AIx, augmentation index; BP, blood pressure; CO, cardiac output; DBP, diastolic blood pressure;
GLP-1, glucagon-like peptide 1; HR, heart rate; iAUC, incremental AUC; MAP, mean arterial pressure; NOx, nitrite, nitroso compounds (RXNO) and
S-nitrosothiols; PP, pulse pressure; PROPRES, randomised clinical trial on the effects of PROteins on blood PRESsure; PWV, pulse wave velocity;
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British Journal of Nutrition (2014), 112, 600–608 doi:10.1017/S0007114514001251


















Downloaded from https://www.cambridge.org/core. Rijksuniversiteit Groningen, on 08 Nov 2018 at 11:23:04, subject to the Cambridge Core terms of use, available at
(PROPRES), we found that the consumption of 60 g/d of a pro-
tein mix for 4 weeks lowered BP compared with that of 60 g/d
of maltodextrin(6). Additional research in a subgroup of the
PROPRES study has shown that the acute BP responses to
the ingestion of mixed meals supplemented with the protein
mix or maltodextrin differed. We found a smaller postprandial
decrease in BP after the ingestion of a protein-supplemented
meal than after that of a maltodextrin-supplemented meal,
and we suggested that differences in insulin responses might
explain these differences in the postprandial BP responses(7).
From this study, it remained unclear whether the differences
in BP responses after carbohydrate and protein intake can
be generalised to ingestion of any kind of proteins and
carbohydrates or are dependent on the type of protein or
carbohydrate ingested. The aim of the present study was to
investigate postprandial BP responses to the ingestion of pro-
teins and carbohydrates from different sources. An additional
objective was to explore the mechanisms via which different
dietary factors affect BP. Postprandial responses are of interest
because in clinical practice BP is often measured in the post-
prandial state and may therefore be influenced by prior meal
ingestion. Moreover, prognostic epidemiological data are
usually based on BP measurements taken during daily clinical
practice, which are mostly not recorded in the fasted state.
We hypothesised that lower postprandial total peripheral resist-
ance (TPR) and BP levels would be accompanied by higher
postprandial concentrations of plasma nitric oxide (NO). NO
is a potent vasodilator produced in the vascular endothelium.
Several hormones, such as insulin and glucagon-like peptide-
1 (GLP-1), and amino acids, such as arginine, may increase
endothelial NO release(8–10). The concentrations of these
hormones and amino acids may be affected by protein
ingestion(11–14). Therefore, our second hypothesis was that
higher postprandial NO concentrations would be accompanied
by higher concentrations of insulin, GLP-1 and/or glucagon.
Glucagon has been hypothesised to increase NO production
because of its vasodilatory effects; however, these effects can
differ between vascular beds(15) and the effects of glucagon
on NO release may be dependent on the condition stu-
died(16,17). In the present study, the postprandial effects of
pea, milk and egg-white protein isolates were compared.
These proteins were selected because they were included in
the protein mix that lowered BP in the PROPRES study(6).
In addition, we investigated whether the choice of our
carbohydrate control in the PROPRES study(6) could have influ-
enced our previous findings. Most studies on the
BP-lowering effect of proteins have compared the effects of
dietary proteins with those of carbohydrates(18). However, BP
may respond differently after the consumption of different
carbohydrate sources(19). Therefore, we chose to compare the
postprandial effects of maltodextrin with those of sucrose,
a widely consumed carbohydrate (table sugar) with a less
pronounced insulin response compared with maltodextrin.
We hypothesised that TPR and BP would decrease more after
the consumption of maltodextrin than after that of sucrose
due to a greater insulin response. Responses to the ingestion
of maltodextrin were also compared with those to the ingestion
of the protein mix tested in the PROPRES study(6).
Subjects and methods
Subjects
Subjects were recruited through local newspapers and via our
database of subjects of the PROPRES study(6). Inclusion and
exclusion criteria for the determination of subject eligibility
were similar to those of the PROPRES study(6). The present
study was conducted according to the guidelines laid down
in the Declaration of Helsinki, and all procedures involving
human subjects were approved by the medical ethics committee
of Maastricht University Medical Center and Maastricht Univer-
sity (METC azM/UM). Written informed consent was obtained
from all the subjects. The study was conducted at Maastricht
University (Netherlands) between January and December 2011.
Study diets and design
The present study was a double-blind, six-arm randomised
cross-over trial. If eligible, the subjects were enrolled for a
run-in period of 2 weeks, during which they followed stan-
dard dietary advice as described previously(6). If their BP
still met the inclusion criteria after the 2-week run-in period,
the subjects were randomised to one of the six treatment
orders using a computer program (MINIM; Stephen Evans,
Simon Day and Patrick Royston; http://www-users.york.ac.
uk/,mb55/guide/minim.htm). The subjects followed the diet-
ary advice until the end of the study. This trial was registered
at http://www.trialregister.nl: as NTR2678.
Test meals were six different powders containing either a
protein or a carbohydrate mixed with H2O at a ratio of 1:4
and were consumed on six separate test days with a washout
period of 1 week between each test. The test meals consisted
of 0·6 g of protein or carbohydrate per kg body mass. Protein
products tested were a pea protein isolate (Roquette), a milk
protein isolate (DMV International), an egg-white protein
isolate (Noventum Foods), and a mix of protein isolates
consisting of 20 % pea protein, 20 % soya protein (ADM Speci-
alty Food Ingredients), 30 % milk protein and 30 % egg-white
protein. Carbohydrate products tested were maltodextrin
(Syral) and sucrose (Suiker Unie). All the test products were
of food grade. The test powders were matched for fat and
mineral content (Table 1) and mixed by NIZO food research.
The amino acid compositions of the protein isolates are given
in Table 2. The researchers and subjects were blinded to the
meals. On the day before each test day, all the subjects con-
sumed the same foods, which were provided by the research-
ers (15 % energy from protein, 30 % energy from fat and 55 %
energy from carbohydrate). On the test day, the subjects
arrived at the university at 08.00 hours after an overnight
fast. The test meals were consumed at T0. Measurements
were taken at time points 21, þ 1, þ 2, þ 3 and þ 4 h.
Measurements
During the screening visit and run-in period, BP and heart rate
(HR) measurements were taken as described previously(6). On
the test day, systolic blood pressure (SBP), diastolic blood
pressure (DBP), mean arterial pressure (MAP) and HR were
measured using a Spacelabs 90 207 (Spacelabs Healthcare
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Limited), a validated automated BP monitor(20), with the sub-
jects sitting on a bed in a semi-supine position. Cardiac output
(CO) and stroke volume were measured non-invasively using
the Finometer MIDI and BeatScope Easy software (Finapres
Medical Systems)(21). TPR was calculated from the MAP and
CO as described previously(7). Pulse pressure (PP) was
calculated as follows: SBP 2 DBP. The central augmented
pressure:pulse height ratio (augmentation index (AIx)) was
derived from pulse wave analysis at the arteria radialis using
the SphygmoCor CP system (Atcor Medical) and corrected
for a HR of 75 beats/min. Pulse wave velocity (PWV) was
measured using the Vicorder (Skidmore Medical Limited).
PWV measurements were taken with one loose cuff around
the neck monitoring pulse waves in the arteria carotis and
another cuff around the upper leg monitoring pulse waves
in the arteria femoralis. PWV was assessed by recording the
distance between the sternal notch and the middle of the
leg cuff and dividing this by the time lag between the pulses
from the carotis and femoralis. PWV was measured three
times, and the average was used in analyses.
Serum and plasma analyses
Blood samples were collected in tubes containing heparin and
lithium for the determination of nitrite, nitroso compounds
(RXNO) and S-nitrosothiols (NOx). The samples in the tubes
were centrifuged within 10 min of collection for 17 min at
48C and 87g. Plasma was collected and stored at 2808C
until analysis. The concentrations of NOx were determined
using a previously described chemiluminescence technique
of Rikilt(22). The concentrations of plasma glucose, GLP-1, gluca-
gon, angiotensin-converting enzyme (ACE) and serum insulin
were measured by MLM Medical Labs. The concentrations of
plasma glucose and serum insulin were determined as
described previously(7). Blood samples were collected in
EDTA collection tubes containing a dipeptidyl peptidase-IV
inhibitor for GLP-1 analysis. The concentrations of active
GLP-1 were measured with an ELISA (Linco Research).
Blood samples were collected in EDTA tubes containing apro-
tinin for glucagon analysis. The concentrations of glucagon
were determined using a RIA (Euro-Diagnostic). The activity
of ACE was also measured, because dietary proteins can
affect BP via the inhibition of ACE(23). The activity of ACE
was determined using the ACE colour method (Fujirebio).
Statistical analyses
Baseline characteristics are reported as means with their stan-
dard errors. Changes in weight between week 3 (end of the
run-in period) and week 8 were tested using a paired t test.
Postprandial responses were analysed with a linear mixed
model approach to take the cross-over design and the corre-
lation between repeated measures into account. The basic
model consisted of a random intercept at the individual
level. If significant, this model was extended with a random
intercept at the meal within the individual level (individual £
meal) or with a serial correlation over time. The basic model
always included the following variables: time; meal; baseline
measurements; two variables controlling for the cross-over
design: meal order and test day number. The interaction
term between meal and time (meal £ time) and the covariates
age, sex and BMI were included in the model if P#0·05. In
case of a significant meal £ time or meal effect, five post hoc
comparisons were made, i.e. maltodextrin v. sucrose, malto-
dextrin v. protein mix, pea protein v. milk protein, pea protein
v. egg-white protein, and milk protein v. egg-white protein.
The critical P value was corrected for these comparisons;
therefore; post hoc differences were considered significant at
P#0·01. To determine whether postprandial changes from
baseline were significant, the incremental AUC (iAUC) was
tested for a significant difference from zero for each meal.
Table 1. Meal compositions for 70 g of protein or carbohydrate
Milk protein Egg-white protein Pea protein Protein mix Maltodextrin Sucrose
Energy (kJ) 1481 1443 1506 1460 1439 1460
Protein (g) 70 70 70 70 0·37 0·36
Carbohydrates (g) 2·8 2·6 2·1 1·7 70 70
Fat (g) 7 6 8 6·9 7 7·5
Fibre (g) 0·9 3·7 1·6 1·9 3·6 1·6
Minerals
Na (mg) 940 980 1010 1060 1050 910
K (mg) 830 700 940 830 710 820
Ca (mg) 1170 1060 1160 1160 1120 1110
P (mg) 900 820 920 910 910 860
Mg (mg) 66 67 73 71 69 62
Table 2. Amino acid compositions (g/100 g) of the protein sources
Milk protein Egg-white protein Pea protein
Ala 2·9 4·3 4·2
Arg 3·7 6 8·7
Asp 6·7 9·6 11·5
Cys 0·6 3 1·1
Glu 19·5 17 17·2
Gly 1·6 3·2 4·2
His 2·5 2·5 2·5
Ile 4·7 4·9 4·8
Leu 8·8 8·4 8·3
Lys 7·5 6·8 7·3
Met 2·6 2·3 1
Phe 4·4 5·1 5·3
Pro 9·7 6 4·5
Ser 5·1 5·6 5·1
Thr 3·9 4 4
Trp 1·1 1·2 1
Tyr 5 4·2 3·8
Val 6·3 5·8 5
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This was done using a one-sample t test and a critical P value
corrected for the six meals (P¼0·0083). All the analyses were
carried out using SPSS software (version 19; IBM). The present
study was powered to show a significant difference in TPR of
at least 1 mmHg/l per min with a SD of 2·2 mmHg/l per min
with a power of 0·8. Based on these values, forty participants
would be needed. The aim was to include fifty participants,
accounting for a dropout rate of 20 %.
Results
Subjects
A total of forty-eight subjects were included in the present
study (Table 3). The subjects lost an average of 0·4 (SEM
0·2) kg of body mass during the six test weeks (P¼0·009).
The carbohydrate test meals were well tolerated, but some
subjects had trouble with fully finishing the protein meals.
Of these subjects, three were unable to finish the pea-protein
meal, three were unable to finish the milk-protein meal, one
subject did not finish the egg-white-protein meal and one sub-
ject did not finish the protein mix meal completely. Because
most of the meal was still consumed in these cases, data
obtained from these subjects were included in all the analyses.
Postprandial responses
Overall, significant time £ meal interactions were found for
SBP, DBP, MAP, HR, AIx, NOx, glucose, insulin, GLP-1 and
glucagon responses after the ingestion of the six meals
(P # 0·03). PP responses to the ingestion of the six meals
differed significantly, independent of time (P ¼ 0·007). Details
on how responses to the ingestion of the six meals differed are
discussed below. TPR, CO, stroke volume, PWV and ACE
responses to the ingestion of the six meals did not differ
significantly.
Responses to the ingestion of egg-white,
milk and pea proteins
The ingestion of the egg-white-protein meal resulted in a
significant increase in SBP, MAP and PP, while that of the
pea-protein meal significantly reduced DBP (iAUC, P#0·001).
At 2–4 h, MAP was significantly higher after the ingestion of
the egg-white-protein meal than after that of meals containing
the other two proteins (P#0·01). SBP and DBP were also sig-
nificantly higher after the ingestion of the egg-white-protein
meal than after that of meals containing the other two proteins
at most time points (P#0·008; Fig. 1(a)–(c)). PP was signifi-
cantly higher after the ingestion of the egg-white-protein
meal than after that of the milk-protein meal, independent
of time (P¼0·009, data not shown). The ingestion of the
pea-protein meal significantly decreased TPR and increased
HR, while only the ingestion of the milk-protein meal
significantly increased CO (iAUC, P#0·005; Fig. 1(d)–(f)).
Postprandial HR was significantly higher after the ingestion
of the pea-protein meal than after that of the egg-white-
protein meal between 1 and 3h (P#0·008; Fig. 1(d)). The
ingestion of all the three protein meals resulted in a decrease in
the AIx (iAUC, P#0·001). The AIx was significantly higher after
the ingestion of the egg-white-protein meal than after that of the
pea-protein meal at 1 h and higher than that after the ingestion of
the milk-protein meal at 3 h (P#0·002; Fig. 1(g)).
Plasma NOx concentrations were significantly increased
after the ingestion of the pea- and milk-protein meals (iAUC,
P#0·0001). NOx concentrations were significantly higher
after the ingestion of the pea-protein meal than after that of
meals containing the other two proteins at 1–3 h (P#0·006;
Fig. 1(h)). The ingestion of all the three protein meals signifi-
cantly reduced plasma glucose concentrations and increased
insulin concentrations (iAUC, P#0·0001; Fig. 1(i) and (j)).
No differences were observed in the postprandial plasma glu-
cose responses to the ingestion of all the three protein meals
(Fig. 1(i)). Serum insulin concentrations were significantly
lower at 1–3 h after the ingestion of the egg-white-protein
meal than after that of the milk-protein meal and at 1–2 h
compared with those after the ingestion of the pea-protein
meal (P#0·0001). Serum insulin concentrations were signifi-
cantly higher after the ingestion of the milk-protein meal
than after that of the pea-protein meal after 4 h (P¼0·009;
Fig. 1(j)). Postprandial plasma glucagon concentrations were
increased after the ingestion of all the three protein meals
(iAUC, P#0·0001; Fig. 1(k)), but remained lowest after the
ingestion of the egg-white-protein meal than after that of
meals containing the other two proteins at 1–3 h (P#0·009).
At 1–2 h, plasma glucagon concentrations observed after the
ingestion of the pea-protein meal also differed significantly
from those observed after the ingestion of the milk-protein
diet, with the highest plasma glucagon concentrations being
detected after the ingestion of the pea-protein meal
(P#0·003; Fig. 1(k)). Plasma GLP-1 concentrations were
increased after the ingestion of all the three protein meals
(iAUC, P#0·0001; Fig. 1(l)), but were significantly lower
after the ingestion of the egg-white-protein meal than after
that of meals containing the other two proteins after 2 h
(P#0·0001) while being higher after the ingestion of the
egg-white-protein meal than after that of the pea-protein
meal after 4 h (P¼0·002; Fig. 1(l)). Plasma ACE activity was
significantly decreased after the ingestion of the pea-protein
meal (iAUC, P¼0·005, data not shown); however, no differ-
ences were observed in the plasma ACE activity responses
to the ingestion of the three protein meals.
Table 3. Baseline characteristics of the study participants





Age (years) 58 1
BMI (kg/m2) 28·6 0·3
Fasting plasma glucose (mmol/l) 5·5 0·1
eGFR* (ml/min per 1·73 m2) 99 3
SBP during the run-in period (mmHg) 144 1
DBP during the run-in period (mmHg) 92 1
eGFR, estimated glomerular filtration rate; SBP, systolic blood pressure; DBP,
diastolic blood pressure.
* Estimated by the modification of the diet in renal disease formula.
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Responses to the ingestion of maltodextrin compared with
those to the ingestion of the protein mix and sucrose
DBP and MAP were significantly decreased after the ingestion
of the maltodextrin meal (iAUC, P#0·0004), but not after that
of the protein mix or sucrose meal. SBP was not significantly
increased or decreased after the ingestion of any of the three
meals. PP was significantly increased after the ingestion of the
protein mix meal (iAUC, P¼0·0001, data not shown). SBP,
DBP and MAP were significantly lower at 1 h after the inges-
tion of the maltodextrin meal than after that of the sucrose
and protein mix meals (P#0·003). DBP and MAP were also
significantly lower after the ingestion of the maltodextrin
meal than after that of the sucrose meal after 2 h (P#0·004;
Fig. 2(a)–(c)). TPR was significantly decreased after the inges-
tion of the protein mix meal (iAUC, P¼0·0001; Fig. 2(f)), while
HR and CO were significantly increased after the ingestion of
this meal (iAUC, P#0·001; Fig. 2(d) and (e)). TPR, CO and HR
did not change significantly after the ingestion of the malto-
dextrin or sucrose meal. Postprandial HR was significantly
higher after the ingestion of the protein mix meal than after
that of the maltodextrin meal after 2–4 h (P#0·0001;
Fig. 2(d)). The AIx was significantly decreased after the inges-
tion of the maltodextrin and protein mix meals (iAUC,
P#0·0001), but not after that of the sucrose meal. The AIx
was significantly higher at 2 h after the ingestion of the sucrose
meal than after that of the maltodextrin meal (P¼0·005;
Fig. 2(g)).
Plasma NOx concentrations were significantly increased
after the ingestion of the protein mix meal (iAUC,
P#0·0001). NOx concentrations were significantly higher at
1–2 h after the ingestion of the protein mix meal than after
that of the maltodextrin meal (P#0·008), but were lower
at 2 h after the ingestion of the sucrose meal than after that
of the maltodextrin meal (P¼0·002; Fig. 2(h)). The ingestion
of the maltodextrin meal resulted in significant increases in
glucose and insulin concentrations (iAUC, P#0·0001).
The ingestion of the sucrose and protein mix meals also
increased insulin concentrations (iAUC, P#0·0001). In
addition, the ingestion of the protein mix meal significantly
lowered plasma glucose concentrations (iAUC, P#0·0001;
Fig. 2(i)–(j)). The ingestion the maltodextrin meal resulted
in significantly higher plasma glucose concentrations at
1–2 h and serum insulin concentrations at 1–3 h compared
with that of the sucrose meal (P#0·002). Compared with
those observed after the ingestion of the protein mix meal,
plasma glucose and serum insulin concentrations were signifi-
cantly higher at 1–2 h after the ingestion of the maltodextrin
meal and significantly lower at 3–4 h after that of the malto-
dextrin meal (P#0·0001). Plasma glucagon concentrations
were significantly decreased after the ingestion of the malto-
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Fig. 1. Changes in (a) systolic blood pressure (SBP), (b) diastolic blood pressure (DBP), (c) mean arterial pressure (MAP), (d) heart rate (HR), (e) cardiac output
(CO), (f) total peripheral resistance (TPR), (g) augmentation index, (h) nitrite, nitroso compound and S-nitrosothiol (NOx), (i) glucose, (j) insulin, (k) glucagon and
(l) glucagon-like-peptide 1 (GLP-1) responses. Values are means, with their standard errors represented by vertical bars. For SBP, DBP, MAP, HR, augmentation
index, NOx, glucose, insulin and glucagon: n 47 for pea protein and egg-white protein; n 48 for milk protein. For CO and TPR: n 47 for pea protein and egg-white
protein; n 46 for milk protein. For GLP-1: n 47 for pea protein; n 48 for milk protein; n 45 for egg-white protein. *, †, ‡ Significant differences between protein
sources (A, pea protein; S, milk protein; W, egg-white protein) shown by post hoc tests with Bonferroni correction (P#0·01) if the time £ meal interaction was
significant (P#0·05; linear mixed model). * Comparison of egg-white protein v. milk protein. † Comparison of egg-white protein v. pea protein. ‡ Comparison of
milk protein v. pea protein.
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the ingestion of the protein mix meal (iAUC, P#0·0001;
Fig. 2(k)). Glucagon concentrations observed after the inges-
tion of the maltodextrin meal did not differ from those
observed after the ingestion of the sucrose meal. Glucagon
concentrations were significantly higher after the ingestion
of the protein mix meal than after that of the maltodextrin
meal at 1–4 h (P#0·0001). GLP-1 concentrations were signifi-
cantly increased after the ingestion of the maltodextrin and
protein mix meals (iAUC, P#0·0001; Fig. 2(l)). GLP-1 concen-
trations were significantly higher at 1 h after the ingestion of
the maltodextrin meal than after that of the sucrose meal
(P#0·0001). After 2–4 h, GLP-1 concentrations were signifi-
cantly higher after the ingestion of the protein mix meal
than after that of the maltodextrin meal (P#0·0001; Fig. 2(l)).
ACE activity was significantly decreased after the ingestion of
the maltodextrin and protein mix meals (P#0·001, data not
shown); however, there were no differences in the postpran-
dial ACE activity responses to the ingestion of the maltodex-
trin, sucrose and protein mix meals.
Discussion
In the present study, we compared the acute postprandial
BP-related responses to the ingestion of egg-white, milk and
pea proteins and we compared postprandial BP-related
responses to the ingestion of maltodextrin with those to the
ingestion of sucrose and a protein mix.
When comparing the protein sources, egg-white protein
was found to induce the highest postprandial BP levels com-
pared with the pea and milk proteins. We hypothesised that
NO-induced vasodilation might be the mechanism responsible
for lowering TPR and consequently BP. The higher BP levels
and lower NOx response observed after the ingestion of the
egg-white-protein meal compared with the levels observed
after the ingestion of the pea-protein meal are in agreement
with this hypothesis, but the BP levels following the ingestion
of the milk-protein meal were lower than those following the
ingestion of the egg-white-protein meal, despite a similar NOx
response. An additional mechanism, such as ACE inhibition,
might have influenced the BP response after the ingestion of
the milk-protein meal(23), but we did not find significant differ-
ences in the postprandial plasma ACE activity responses to the
ingestion of the protein meals. In addition, we found no differ-
ences in TPR or CO responses to the ingestion of the protein
sources. We also hypothesised that NO could be induced by
insulin, glucagon and GLP-1(9,10,15). In accordance with this,
pea protein induced the highest hormonal and NOx responses,
while egg-white protein induced the lowest responses. The
higher amount of arginine in pea protein could have also con-
tributed to the higher NOx response
(8). However, milk protein
induced a low NOx response, despite inducing intermediate
hormonal responses. NO regulation is complex and is
influenced by many pathways. For instance, leptin is also


















































































































































































































































Fig. 2. Changes in (a) systolic blood pressure (SBP), (b) diastolic blood pressure (DBP), (c) mean arterial pressure (MAP), (d) heart rate (HR), (e) cardiac output
(CO), (f) total peripheral resistance (TPR), (g) augmentation index, (h) nitrite, nitroso compound and S-nitrosothiol (NOx), (i) glucose, (j) insulin, (k) glucagon and
(l) glucagon-like-peptide 1 (GLP-1) responses. Values are means, with their standard errors represented by vertical bars. For SBP, DBP, MAP, HR, augmentation
index, glucose, insulin and glucagon: n 47 for maltodextrin and sucrose; n 48 for the protein mix. For CO, TPR, glucose, insulin, glucagon and GLP-1: n 47 for
maltodextrin; n 48 for the protein mix; n 46 for sucrose. For NOx: n 46 for maltodextrin and sucrose; n 48 for the protein mix. * Significant differences between mal-
todextrin (X) and the protein mix (D) shown by post hoc tests with Bonferroni correction (P#0·01) if the time £ meal interaction was significant (P#0·05; linear
mixed model). † Significant differences between maltodextrin and sucrose (B) shown by post hoc tests with Bonferroni correction (P#0·01) if the time £ meal inter-
action was significant (P#0·05; linear mixed model).
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insulin-induced NO release(16). In addition, several proteins
and amino acids have been reported to affect NO synthesis in
a variety of tissues(25).
The AIx was decreased after the ingestion of all the three
protein meals, which indicates that the diameter or distensibil-
ity of arteries or arterioles was increased(26). A postprandial
decrease in AIx has been reported previously(27). The smaller
decrease in AIx after the ingestion of the egg-white-protein
meal could be due to the lower insulin response. Westerbacka
et al.(26) demonstrated that a physiological dose of insulin can
decrease AIx within 1 h.
Differences in insulin- and glucagon-stimulating properties of
different proteins have been reported previously(11,13,28) and
may be explained by differences in the amino acid composition.
Phenylalanine and glycine, which are present in highest
amounts in pea protein, have been found to be more
insulinotropic compared with other amino acids(12). Glycine
and arginine, also most abundant in pea protein, have been
found to be have higher glucagon-stimulating properties(12).
Branched-chain amino acids, which are more common in
milk proteins, have also been reported to have higher insulin-
stimulating properties(11). Differences in the rate of digestion
can also influence postprandial insulin responses as shown in
studies comparing insulin responses to the consumption of
the fast protein whey and the slow protein casein(29,30).
However, the relative rates of digestion of the proteins in the
present study are unknown. GLP-1 responses to the ingestion
of the different protein sources did not seem to differ much.
Limited and conflicting data have been reported in the literature
on the effects of different proteins on GLP-1 concentrations. No
differences were found in GLP-1 concentrations by two studies
after the consumption of meals containing 18 g of milk, cheese,
whey, cod or wheat gluten protein combined with 25 g of carbo-
hydrates(31) or after the consumption of different amino acid
mixtures containing isoleucine, leucine, valine and/or
threonine, lysine and whey protein supplemented with 25 g
carbohydrates(32). A higher GLP-1 response was found by one
study after the consumption of whey protein than after that of
casein(14). Thus, as hypothesised, the lower BP levels observed
after the ingestion of the pea-protein meal compared with the
levels observed after the ingestion of the egg-white-protein
meal was accompanied by higher NOx, insulin, glucagon and
GLP-1 responses. However, the lower BP response and higher
insulin, glucagon and GLP-1 responses observed after the inges-
tion of the milk-protein meal compared with the responses
observed after the ingestion of the egg-white-protein meal
were not accompanied by higher plasma NOx concentrations.
Therefore, lower postprandial BP levels and higher concen-
trations of serum insulin and plasma glucagon and GLP-1 are
not always accompanied by higher plasma NOx concentrations.
When comparing maltodextrin and sucrose, we found
significantly lower BP levels after the ingestion of the malto-
dextrin meal. It has previously been suggested that this may
be due to the fructose content of sucrose, but a recent meta-
analysis has found no significant effect of prolonged fructose
intake on BP in human trials(33). We hypothesised that the
lower BP levels could be due to a higher NOx response.
Indeed, we found significantly higher NOx concentrations
after the ingestion of the maltodextrin meal, but only at 2 h.
We did not find significant changes in TPR, CO and HR after
the ingestion of either carbohydrate. An acute study in healthy
subjects found a higher BP increase after fructose consump-
tion than after glucose consumption(19). In contrast to the
present study, this study also reported a greater decrease in
TPR and a greater increase in CO after glucose consump-
tion(19). A study in healthy elderly subjects (65–78 years)
reported that the decrease in SBP, DBP and MAP was similar
1 h after the consumption of a beverage containing 50 g glu-
cose compared with that observed after the consumption of
a beverage containing sucrose(34). Another study comparing
a glucose drink with a glucose–fructose drink (45 g glucose
and 55 g fructose) only found a higher HR after the consump-
tion of the glucose–fructose drink, with no differences being
detected in BP, PWV and nitrite:nitrate in 90 min AUC(35). The
higher insulin and GLP-1 responses induced by the higher glu-
cose content of maltodextrin in combination with the higher
NOx response compared with the responses observed after
the ingestion of the sucrose meal support our second hypoth-
esis that NOx may be induced by these hormones. Others have
also reported higher insulin responses after the consumption
of glucose than after that of fructose(36–38), while GLP-1 con-
centrations have been found either to be higher(36) or to not
differ(38). However, the time points at which the differences
in insulin and GLP-1 responses were observed in the present
study were not completely in agreement with our hypothesis,
as the concentrations of both hormones were highest after 1 h,
while NOx concentrations were higher at 2 h. The AIx was sig-
nificantly lower after the ingestion of the maltodextrin meal
than after that of the sucrose meal at 2 h, which may be due
to the higher insulin response(26).
When comparing BP responses to the ingestion of the pro-
tein mix and maltodextrin, we did find lower BP levels at 1 h
after the ingestion of the maltodextrin meal, as we found in the
PROPRES study(7). In contrast to the PROPRES study, in which
both the carbohydrate and protein meals induced a decrease
in BP, the protein meals induced no change or an increase
in BP in the present study. However, in the present study, pro-
teins and maltodextrin were tested separately, while in the
PROPRES study both were consumed with a mixed meal(7).
We hypothesised that lower postprandial BP levels would be
accompanied by a higher NOx concentration, which decreases
TPR by inducing vasodilation. The NOx response was higher
after the ingestion of the protein mix meal, which could
have contributed to the decrease in TPR. The reduction in
TPR induced by the protein mix was accompanied by
increases in HR and CO, which may explain why BP was
not significantly affected by the protein mix. Despite these sig-
nificant haemodynamic changes after the ingestion of the pro-
tein mix meal, we did not find significant differences in TPR,
CO and HR responses to the ingestion of the protein mix
and maltodextrin meals, while we did find a difference in
TPR responses in the PROPRES study(7). It may be that the
energy content of the test meals used in the present study
was not high enough to detect differences in TPR responses
to the ingestion of the test meals. As maltodextrin did not
induce a significant change in CO or TPR, it is not clear
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from our data why BP was reduced after the ingestion of the
maltodextrin meal.
Our second hypothesis was that higher NOx responses might
be accompanied by increased concentrations of insulin, GLP-1
and glucagon, as these hormones may induce their vasoactive
properties via NO-dependent vasodilation(9,10,17). In accord-
ance with this, the higher NOx response observed after the
ingestion of the protein mix meal was accompanied by higher
GLP-1 and glucagon responses. GLP-1 responses observed
after the ingestion of dietary proteins have been reported to
be either higher than(38) or similar to(39,40) those observed
after the ingestion of carbohydrates. However, the study carried
out by Li et al.(40) measured GLP-1 responses only once after
36 min, while in the present study the difference in GLP-1
responses was detected after 120 min. Karamanlis et al.(39) did
measure responses at 180 min, but their study may have been
underpowered to detect differences in GLP-1 responses,
because it included only nine subjects. The higher glucagon
response observed after protein consumption was expected,
because the maltodextrin-stimulated insulin increase would
inhibit glucagon release to maintain glucose homeostasis,
while dietary protein is known to be a stimulus for glucagon
release(11). In addition, arginine, which was present in the pro-
tein mix, could also have contributed to the higher NOx
response after protein consumption(8). In our previous study,
we had hypothesised that the increase in insulin response
after maltodextrin intake could have induced the decrease in
BP after maltodextrin intake(7). In the present study, however,
we found no maltodextrin-induced changes in TPR or NOx
responses to support this hypothesis. In addition, no differences
were observed in the AIx and ACE activity responses to the
ingestion of the maltodextrin and protein mix meals. Therefore,
the mechanisms involved in the decrease of BP after maltodex-
trin consumption remain unknown.
The increased or unchanged BP levels observed after
protein consumption in the present study contradict the
BP-lowering effect after long-term consumption of dietary
proteins that has been reported in many studies(1,2). However,
the PROPRES study has already demonstrated that postpran-
dial responses are not necessarily similar to the effects of
long-term consumption(7). High-carbohydrate diets could
increase BP in the long term via insulin-induced Na retention,
because insulin reduces hyperglycaemia-induced Na
excretion(41). As we included only participants with fasting
glucose levels ,7 mmol/l, it is unlikely that this mechanism
plays a role in the subjects of the present study. Supporting
this, we found no differences in Na excretion in urine samples
collected after each test (data not shown). Postprandial
responses cannot be directly extrapolated to the effects of
chronic protein consumption. Therefore, long-term studies
are necessary to determine which protein source could be
most beneficial in BP management.
In conclusion, we found no significant differences in TPR
responses after the ingestion of the six meals. Higher BP
responses were found after the ingestion of the egg-white-
protein meal than after that of the pea- and milk-protein
meals and lower BP after the ingestion of the maltodextrin
meal than after that of the protein mix and sucrose meals.
However, larger postprandial reductions in BP after the inges-
tion of different meals are not necessarily accompanied by
higher increases in NOx concentrations. This is not surprising
as BP is regulated by many factors not by NO only. We also
found that higher postprandial NOx responses were not
necessarily accompanied by higher insulin, glucagon and
GLP-1 concentrations. Mechanisms through which different
proteins and carbohydrates acutely affect TPR and BP
remain unclear. These data reveal that different protein and
carbohydrate sources can induce different postprandial BP-
related responses and thus effects of chronic consumption
may also differ between different protein sources.
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